Thyroid Hormone Receptor and Runx2 Expression in Thyroid Cancer Cells
Frances Carr, PhD, professor, Department of Pharmacology, The University of Vermont, discusses the relationship between the thyroid hormone receptor and Runx2 expression in thyroid cancer cells.
References
Frances Carr, PhD, professor, Department of Pharmacology, The University of Vermont, discusses the relationship between the thyroid hormone receptor and Runx2 expression in thyroid cancer cells.
- The thyroid hormone receptor is a possible tumor suppressor.
- Studies have shown that Runx2 may be a tumor promoter in papillary thyroid cancer.
- An inverse relationship was seen between thyroid hormone receptor expression and Runx2.
- This relationship is being explored and could have therapeutic implications in the future.
Recent Videos
Related Content
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023Podcast
In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
